SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-377546
Filing Date
2012-08-31
Accepted
2012-08-31 16:08:00
Documents
4
Period of Report
2012-08-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d403600d8k.htm 8-K 25344
2 COMMON STOCK PURCHASE AGREEMENT d403600dex101.htm EX-10.1 401328
3 PRESS RELEASE d403600dex991.htm EX-99.1 9432
4 GRAPHIC g403600ex99_1pg1.jpg GRAPHIC 15387
  Complete submission text file 0001193125-12-377546.txt   458564
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34828 | Film No.: 121068638
SIC: 2834 Pharmaceutical Preparations